This strong pharmacological rescue capacity of VX-661-VX445 combination was previously demonstrated on primary bronchial epithelial cells derived from F508del homozygous patient [35,41], in our F508del-CFTR organoids and for other class II CF mutants [42,43]. This evidence concerns the gene CFTR and cystic fibrosis.